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i. Summary 
This chapter introduces a set of transposon-based methods that were developed to sample 
trinucleotide deletion, trinucleotide replacement and domain insertion. Each approach has a 
common initial step that utilises an engineered version of the Mu transposon called MuDel. 
The inherent low sequence specificity of MuDel results in its random insertion into target 
DNA during in vitro transposition. Removal of the transposon using a type IIS restriction 
endonuclease generates blunt end random breaks at a frequency of one per target gene and the 
concomitant loss of 3 bp. Self-ligation or insertion of another DNA cassette results in the 
sampling of trinucleotide deletion or trinucleotide substitution/domain insertion, respectively.  
 
ii. Key words: Directed evolution, molecular diversity, Mu transposon, trinucleotide deletion, 
trinucleotide exchange, domain insertion, expanded genetic code.  
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1. Introduction 
Generating molecular diversity lies at the heart of directed evolution (1-4). With an ever-
expanding directed evolution toolbox, different mutational approaches are required. These 
will access sequence space beyond that sampled by simple gene point mutations that 
ultimately restrict sequence, structural and functional diversity (1, 5, 6). Sampling randomly 
introduced point mutations severely limits the amino acid range that can be tested at a 
particular residue position as statistically only one base per codon will ever be mutated (4). 
Furthermore, many traditional directed evolution approaches ignore mutations that alter the 
protein backbone. Such mutations, termed indels (insertion/deletion), are commonly observed 
amongst natural protein homologues (7, 8) and range from single amino acid deletions to the 
insertion of extended protein segments or domains. Mutation of the protein backbone changes 
the structure of a protein in a manner distinct to that of side-chain substitutions, sampling new 
conformational and hence functional space (9). Until recently, generating indel mutations for 
directed evolution libraries was a major challenge for the field. Rational site-directed 
approaches can be used but generally require detailed information regarding structure and 
function to guide mutagenesis. Even armed with such information, the local and global 
structural consequences of rational indel mutagenesis can be difficult to predict.  
To address these challenges, a set of transposon-based approaches were developed to 
sample trinucleotide deletion (10, 11), trinucleotide replacement (12, 13) and domain 
insertion (14-16) (Fig. 1). Each of these approaches relies on a common first step that 
ultimately defines genetic diversity sampled across a target gene and thus protein backbone: 
transposition with an engineered version of the Mu transposon, termed MuDel (10).  
The Mu transposon, or more accurately mini-Mu (17), is a DNA construct that can be 
inserted randomly into a target DNA sequence with high efficiency and accuracy but with low 
target site preference. Transposition is performed in vitro using the commercially available 
MuA transposase. To implement the various mutagenesis strategies mini-Mu is modified 
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symmetrically close to both termini to introduce the recognition sequence for MlyI, a type IIS 
restriction endonuclease that cuts outside its recognition sequence. Placement of the MlyI 
sites within MuDel, in combination with the transposon insertion mechanism, results in the 
removal of 3 bp at random positions within a target gene upon MlyI digestion (Fig. 2). Self-
ligation of the resulting DNA generates a library of proteins with single amino acids deleted 
at random positions.  
Deletion of trinucleotide sequences opens up the possibility of their replacement with a 
new trinucleotide sequence and is the basis for trinucleotide exchange (TriNEx) ((13); Fig. 2). 
This approach uses the expanded amino acid range of site-directed saturation mutagenesis in 
combination with the broader sampling capacity of whole-gene mutagenesis. To implement 
TriNEx an additional DNA cassette termed SubSeq is used, which donates a new 
trinucleotide sequence back to the target gene.  MlyI is used to achieve trinucleotide exchange 
by means of the mechanism outlined in Fig. 2. The donating sequence in SubSeq is 
determined by the user and can be randomized (13) or defined (12). The latter has been used 
to perform non-natural amino acid whole gene directed evolution.  
Domain insertion (18-20) is a powerful approach to generate new protein scaffolds in 
which the functions of normally disparate proteins can be coupled generating new 
components for use in, for example, biosensing, synthetic biology and bionanotechnology. 
Domain insertion is achieved using the MuDel approach by replacing SubSeq with a DNA 
cassette encoding a protein segment of choice (14-16) (Fig. 1). As well as sampling a variety 
of insertion positions across a target gene, the nature of the DNA cassette itself can form the 
basis of a mini-library (Fig. 3). The ends of the DNA cassette can be modified to: (1) 
overcome reading frame artefacts due to cross codon deletion events during MuDel excision 
so increasing the diversity of insertion positions sampled; (2) vary the nature of the linking 
sequences between the host protein and the introduced protein segment/domain.  
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2. Materials 
2.1. Transposition and mutagenesis components 
1. pNOM (10) (see Note 1). 
2. pNOM-XP3 (15) (see Notes 1-3).  
3. Transposons. The key sequence details of the MuDel transposon are shown in Fig. 2 (see 
Notes 4 - 5). 
4. MuA transposase from Finnzymes (now ThermoScientific).   
5. MuA transposase reaction buffer: 25 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 110 mM NaCl, 
0.05% Triton and 10% (v/v) glycerol. This is supplied as 5x reaction buffer.  
6. SubSeq DNA cassette. The SubSeq DNA cassette is required for TriNEx; the essential 
sequence features are shown in Fig. 2 (see Note 6).  
2.2. General materials 
1. Deionised or MilliQTM (MQ) water were used throughout. Water was sterilised by 
autoclave. Ampicillin, kanamycin or chloramphenicol (in ethanol) were made as a 100, 25 or 
34 mg/ml stock solution respectively and filter sterilized with a 0.22 μm filter unit with the 
exception of chloramphenicol. The stock solutions were used to supplement bacterial growth 
media by dilution to an appropriate working concentration.  
2. E. coli cell strains (electro- or chemically competent) with high transformation efficiencies 
(>109 cfu per µg pUC18 DNA) are required. DH5α and NovaBlue (Merck KGaA) strains are 
used for library construction, and various versions of BL21 (DE3) including BL21-Gold 
(DE3) (Stratagene) and Tuner™ (DE3) (Novagen) are used for protein expression. 
3. Luria Bertani Broth (LB) medium: Per litre, mix 5 g yeast extract, 10 g tryptone and 10 g 
NaCl. Autoclave at 121˚C for 25 min and let cool to ambient temperature. 
4. LB-agar medium: Per litre, mix 5 g yeast extract, 10 g tryptone, 10 g NaCl and 15 g agar. 
Autoclave at 121˚C for 25 min and let cool to 50˚C in a warm water bath. Add appropriate 
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antibiotic selection marker and gently shake to homogenize the solution, then pour plates and 
let agar solidify at room temperature. Plates can be stored at 4˚C for up to 4 weeks 
5.  Molecular biology grade agarose: gels were prepared by boiling 0.6-2.0 % (w/v) in 1X 
TAE buffer (40 mM Tris-acetate, 1 mM EDTA) buffer followed by cooling and addition of 
0.5 µg/mL ethidium bromide. 
6. Restriction endonucleases (with reaction buffers) e.g. MlyI, NdeI and XhoI. 
7. 100x BSA Stock solution: 10 mg/ml in water. 
8. Quick T4 DNA ligase system (NE Biolabs) 
9. T4 polynucleotide kinase  
10. 10x T4 polynucleotide kinase reaction buffer (70 mM Tris-HCl, 10 mM MgCl2, 5 mM 
DTT pH 7.6. 
11. 10x ATP solution: 10mM ATP in water. 
12. APex™ heat-labile alkaline phosphatase (1 unit/µg DNA) (Epicentre® Biotechnologies)  
13. Oligonucleotide primers: 100 µM stock solutions. 
14. GoTaq® DNA polymerase (Promega) system. 
15. Phusion® High-Fidelity DNA polymerase (NE Biolabs) system.  
16. PCR, gel extraction, MinElute, plasmid Miniprep and plasmid Midi-prep purification kits 
(QIAGEN), used according to the manufacture’s guidelines. DNA concentrations and 
260/280 nm ratios after purification were estimated using a NanoDrop® ND-1000 UV-Vis 
spectrophotometer.  
 
3. Methods 
3.1 MuDel insertion library construction 
Prior to transposition, clone the target gene within the multiple cloning site of pNOM or a 
pNOM-based vector (see Notes 7 & 8).  
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1. Transposition with MuA transposase (ThermoScientific). Add target plasmid DNA (100 ng 
equivalent to pNOM) and MuDel (20-100 ng) to MuA transposase reaction buffer containing 
0.22 µg of MuA transposase in a final volume of 20 µl. Leave reactions at 30°C for 3 h and 
then heat inactivate at 75°C for 10 min. 
2. Transform chemically competent E. coli cells with the equivalent of 5-20 ng of plasmid 
DNA from the deactivated transposition reaction (see Note 9).  
3. Plate a small proportion of transformed cells (~1%) on LB agar plates supplemented with 
20 µg/ml chloramphenicol to assess transposition efficiency and calculate the total number of 
target plasmid molecules containing MuDel. After overnight incubation at 37°C, extrapolate 
the number of colonies back to the number present in the total transformation mixture (see 
Notes 10 & 11). 
4. Use the remaining portion of transformed cells to inoculate 1 L LB broth supplemented 
with 20 µg/ml chloramphenicol and incubate in a shaker at 37°C for 12-16 h. Purify the 
pooled MuDel insertion plasmid DNA library from liquid culture using Qiagen Plasmid Midi 
Kit and store at -20°C (see Note 12). 
5. Isolate MuDel inserted within the target gene, and remove any insertions that have 
occurred within the plasmid, by digesting the pooled plasmid DNA with the original 
restriction enzymes used to clone the target gene into pNOM or its derivatives (e.g. NdeI and 
XhoI). Separate the resulting fragments by agarose gel electrophoresis. Restriction digestion 
will produce 4 DNA fragments: (A) plasmid backbone with MuDel; (B) plasmid backbone 
without MuDel; (C) target gene with MuDel; (D) target gene without MuDel.  
6. Isolate the two bands corresponding to fragments B and C and purify the DNA from the gel 
matrix using a QIAquick gel extraction kit (QIAGEN) 
7. Ligate the two purified fragments using the Quick Ligation™ Kit (NE Biolabs) and 
transform into E. coli. As the two DNA fragments originated from the same restriction 
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digestion they may be presumed to be equimolar, so use appropriate volumes of each 
fragment in the ligation reaction to sample from 1:1 to 3:1 insert to vector ratios. 
8. To calculate the total number of clones containing MuDel that comprise the library, plate a 
small proportion of transformed cells (~1%) on LB agar plates supplemented with 20 µg/ml 
chloramphenicol. After overnight incubation at 37°C, extrapolate the number of colonies back 
to the number present in the total transformation mixture (see Note 13).  
9. Use the remaining portion of transformed cells to inoculate 1L LB broth supplemented with 
20 µg/ml chloramphenicol and incubate in a shaker at 37°C for 12-16 h. Purify the pooled 
MuDel target gene insertion plasmid DNA library from liquid culture and store at -20°C (see 
Notes 14 & 15). 
 
3.2 Construction of trinucleotide deletion library (TND) 
The initial MuDel library constructed as outlined in Subheading 3.1 is the basis for TND 
library generation. At this stage, all the clones present in the MuDel library are assumed to 
have MuDel inserted within the target gene. 
1. Remove MuDel from transposon-insert library by digestion with MlyI (NE Biolabs). 
Perform digestion with 1 U of enzyme per µg DNA in NEBuffer 4 supplemented with 0.1 
mg/ml BSA in a total reaction volume of 50 µl. Incubate the reaction at 37°C for 1 h/µg DNA 
(see Note 16).  
2. Separate the resulting DNA fragments by agarose gel electrophoresis. Extract the DNA 
fragment equivalent to the size of the original starting plasmid (pNOM or derivative) plus the 
target gene using a QIAquick gel extraction kit (QIAGEN). Discard the MuDel band.  
3. Re-circularise the purified linear library DNA (50 ng) by intramolecular ligation with the 
Quick Ligation™ Kit (NE Biolabs). Incubate ligation reactions at 25°C for 20 min (see Note 
17).  
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4. Use 1 µl of the ligation reaction mixture to transform E. coli electrocompetent or 
chemically competent cells. Grow transformed cells on LB agar plates supplemented with 100 
µg/ml ampicillin (see Note 18).  
5. The library can now be screened to identify protein variants with desired properties. 
 
3.3. Construction of a Trinucleotide exchange (TriNEx) library 
The initial MuDel library constructed as outlined in 3.1 will be the basis for generating the 
TriNEx library. At this stage, all the variants present will be deemed to have MuDel inserted 
within the target gene. 
1. Generate the SubSeq DNA cassette (Fig. 2) by PCR as outlined in 2.1.4.  Phosphorylate the 
SubSeq PCR product using 10 U T4 polynucleotide kinase (NE Biolabs) in 1 x T4 
polynucleotide kinase reaction buffer (NE Biolabs) and 1 mM ATP. Incubate the reaction at 
37°C for 1 h then heat inactivate at 65°C for 20 min. Purify the resulting DNA using the 
QIAquick PCR purification kit. 
2. Remove MuDel from the pooled plasmid DNA by digestion with MlyI as outlined in 
Subheading 3.2.1. Dephosphorylate digested DNA by adding APex heat-labile alkaline 
phosphatase (1 unit/µg DNA) (Epicentre Biotechnologies) to the restriction endonuclease 
reaction and incubate at 37°C for the duration of the restriction digest. Heat inactivate the 
phosphatase and MlyI by incubating the reaction mixture at 70°C for 5-10 min.  
3. Separate the resulting DNA digest by agarose gel electrophoresis and extract the fragment 
equivalent to the size of the original starting plasmid (pNOM or derivative) plus the target 
gene from the gel. 
4. Ligate the SubSeq DNA cassette into linear plasmid DNA with T4 DNA ligase for 30 min 
at room temperature. In a total volume of 20 µl, use a molar ratio of 1:3 (pNOM:SubSeq) with 
a total of 200-250ng DNA in each reaction (see Note 19).  
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5. Electroporate 2 µl of the ligation reaction (1/10th) into E. coli DH5α cells. Calculate the 
number of transformed cells containing SubSeq incorporated within the host plasmid, by 
plating the equivalent of 2-3% of the electroporated cells on LB agar plates supplemented 
with 25 µg/ml kanamycin. Incubate the plates overnight at 37°C and then count the number of 
colonies observed to calculate ligation and transformation efficiency. The observed 
transformation efficiency is expected to be 3-4 x 104 cfu/µg DNA (see Note 20).  
6. Add the remaining portion of transformed cells to 50 ml of LB broth containing 200 µg/ml 
kanamycin and incubate in a shaking incubator at 37°C for 16 h.  
7. Isolate plasmid DNA from the culture using a QIAprep spin miniprep kit (QIAGEN) and 
store at -20°C (see Note 21).  
8. Digest the purified plasmid DNA (2 µg) with MlyI for 1 h at 37°C (Subheading 3.2.1) to 
remove the SubSeq section, with the terminal trinucleotide sequence of SubSeq donated to the 
target gene. Agarose gel electrophoresis was used to separate excised SubSeq from linearised 
DNA corresponding to the host plasmid containing the target gene.  Extract the latter from the 
gel as outlined in Subheading 3.2.2. 
9. Re-circularise the linear plasmid DNA (~50-100 ng) using T4 DNA ligase as outlined in 
Subheading 3.2.3. 
10. Transform the resulting library as outlined in Subheading 3.2.4. 
11. The library can now be screened to identify protein variants with the required properties.  
 
3.4. Construction of a Domain Insertion library 
The MuDel library constructed as outlined in Subheading 3.1 is the basis for generating 
the Domain Insert library. At this stage, all the variants present are assumed to have MuDel 
inserted within the target gene. 
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1. Construct the DNA cassette comprising the protein segment/domain insert by PCR using 
the Phusion High Fidelity DNA polymerase system (NE Biolabs). The general strategy for 
constructing the domain insert is outlined in Fig. 3. Design terminal oligonucleotides to 
incorporate linker sequence and open reading frame (ORF) requirements. With regards to the 
latter, design different ORF versions of the DNA insert cassette to take into account cross-
codon trinucleotide deletions inherent on MuDel excision. This increases DNA cassette 
insertion position diversity within the target gene (see Note 22).  
2. Phosphorylate the different ORF DNA insertion cassettes as outlined in Subheading 3.3.1.  
3. Remove MuDel from the pooled plasmid DNA containing the target gene and 
dephosphorylate as outlined in Subheading 3.3.2. 
4. Ligate the DNA insert cassette into linear plasmid DNA using T4 DNA ligase for 30 min at 
room temperature as described in Subheading 3.3.4. Perform individual ligations for each 
ORF version of the DNA insert cassette.  
5. Transform the ligation reactions into E. coli cells by electroporation. Plate transformed 
cells on LB agar supplemented with 100 µg/ml ampicillin and incubate at 37°C for at least 16 
h.  
6. Assess DNA cassette insertion efficiency by screening colonies by colony PCR using the 
GoTaq DNA polymerase (Promega) system and primers flanking the target gene. Positive 
clones will produce an amplified DNA product corresponding to the size of the original target 
gene plus the DNA cassette insert.  
7. Further analyze positive clones by PCR to assess frequency of correct DNA cassette 
insertion orientation and diversity of the insertion position. Use a primer pair comprising a 
target gene flanking primer and a DNA cassette insert construction primer from Subheading 
3.4.1 (see Note 23). 
8. The libraries are now ready to be screened to identify domain/segment insertion variants 
with desired properties.  
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4.  Notes 
1. Plasmids pNOM [10] and pNOM-XP3 [15] are bespoke plasmids available from the 
authors for use with MuDel and host the target gene. pNOM is the original vector and is 
based on pUC18 backbone with pNOM-XP3 being an inducible target gene over-expression 
version of pNOM. pNOM (plasmid NO MlyI) was constructed to remove all MlyI sites 
present in the original pUC18 plasmid (-1 to 1979 bp region) and to incorporate a useful 
multiple cloning site with the common restrictions sites NdeI and XhoI at either end. Removal 
of MlyI sites notably changed 2 bp in the origin of replication and introduced a silent 
mutation in the bla ampicillin resistance gene; neither appeared to be detrimental to the use of 
the plasmid. pNOM-XP3 is a derivative of pNOM containing the inducible T7 promoter 
upstream of the target gene. The original T7 promoter was mutated to remove an MlyI 
recognition sequence. The NdeI recognition sequence is present downstream from the T7 
promoter to aid in-frame initiation codon cloning.  
2. Versions of pNOM-XP3 are available with NcoI in place of NdeI.  
3. Target protein expression can be leaky when using pNOM-XP3.  We assume this is due to 
the mutated T7 promoter.  
4. MuDel was generated from the commercially available CamR containing Mu 
Entranceposon present within the pEntranceposon plasmid 
(http://www.thermoscientificbio.com/mutagenesis/entranceposons/). MuDel was recloned 
back into the pEntranceposon plasmid within the BglII site. MuDel was removed from the 
plasmid for use in the mutagenesis procedure using BglII and separated from the plasmid 
backbone by agarose gel electrophoresis followed by gel excision and purification using the 
Qiagen QIAquick gel extraction kit. 
5. We have tried using PCR amplified forms of MuDel but have found that BglII digested 
transposon from plasmid gives by far the best results. 
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6. The SubSeqNNN DNA cassette was constructed by PCR using the Phusion™ high fidelity 
DNA polymerase system (NE Biolabs). The KanR gene region of the Entranceposon™ (kanR-
3) (Finnzymes) was amplified as two separate fragments to remove an MlyI site in the middle 
of the gene and introduce MlyI sites at strategic positions towards the termini of the cassette. 
The nature of the SubSeq used was determined by a terminal primer 5’[Phos]-
NNNGAAAGGACTCAGTGTGTCGGCGGCCGCGGATCCT-3’ (MlyI site underlined) 
where the 5’ end 3 bp sequence (NNN) that is ultimately donated to the target gene can be 
determined by the user.  
7. It is important that any MlyI sites are removed in the target gene. This can be achieved 
through the use of silent mutations.  
8. Although manufacturers state in vitro transposition into linear DNA with MuA is feasible, 
we have had no success with this approach so have always used circular plasmid DNA as the 
target for MuDel insertion. 
9. Chemically competent cells with high transformation efficiencies (>109 cfu/µg DNA) 
should be used at this stage due to the relatively high concentrations of DNA.  
10. We recommend that the calculated number of colonies should be ~2-3 times the size of 
the target plasmid (plasmid backbone plus target gene) to ensure maximal transposon 
insertion coverage. 
11. Colony PCR (using primers that flank the target gene) can be performed on randomly 
selected colonies as an alternative way to calculate the percentage of the library containing 
MuDel insertions within the target gene. Analysis of amplified products by agarose gel 
electrophoresis should give two amplified products corresponding to: (i) the target gene 
alone; (ii) the target gene plus MuDel (1307 bp). The percentage of analysed colonies with 
the larger size band is representative of the percentage of variants in the library with MuDel 
inserted within the target gene region of the plasmid. 
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12. As an alternative option, the remaining cells may be spread onto 150 mm diameter LB 
agar plates supplemented with 20 µg/ml chloramphenicol. Collecting cells from single 
colonies of roughly equal size straight from plates can help reduce bias which may result from 
different growth rates in liquid media. Ensure single colony resolution by pipetting 150-200 
µl per plate and dispersing cells with a glass spreader. Following overnight incubation at 
37°C, isolate the MuDel library by adding LB broth (5 ml) to each plate and gently shaking 
the plates for 10-15 mins to suspend cells. Collect the LB broth and purify the MuDel 
insertion plasmid DNA library from liquid culture using Qiagen Plasmid Midi Kit and store at 
-20°C.  
13. We recommend that the calculated number of colonies should be >3 times the size of the 
target plasmid (plasmid backbone plus target gene) to ensure maximal transposon insertion 
coverage. 
14. An additional step may be included at this point to confirm MuDel has inserted randomly 
and uniformly across the length of the target gene. The pool of plasmid DNA can be digested 
with MlyI and one of the restriction endonucleases originally used to clone the target gene 
into the host plasmid (e.g. NdeI or XhoI). Analysis of the digestion mixture by agarose gel 
electrophoresis should produce a distinctive band at ~1310 bp corresponding to excised 
MuDel and two smears: one ranging from the size of the host plasmid (e.g. 2146 bp for 
pNOM-XP3) to the size of the original plasmid plus the target gene; another smear ranging 
from the 0 bp to the size of the target gene. We generally use XhoI to clone our target gene 
into pNOM or derivative. Thus we normally analyse MuDel insertion diversity with XhoI and 
MlyI. XhoI serves to linearise the plasmid DNA; the resulting variable length DNA fragments 
are generated by MlyI digestion and depend on the placement of MuDel within the target. 
15. An alternate selection strategy to Subheading 3.1 items 5-9 can be used if a negative 
selection or screen is feasible. All the transformed E. coli cells can be plated on LB agar 
supplemented with chloramphenicol to select for clones containing MuDel within the host 
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plasmid which are subsequently screened for target protein activity. Those colonies that do 
display target protein activity are deemed not to have a disrupted gene due to MuDel 
insertion. Those colonies that do not display target protein activity are deemed to contain 
MuDel inserted within the gene due to disruption of the protein coding region.  
16. It is important to use relatively fresh MlyI at this stage as in some rare instances we have 
observed downstream problems when using older stocks of the restriction endonuclease.  
17. DNA ligated using the Quick Ligation™ Kit protocol must be column purified prior to 
transformation by electroporation. PEG in the Quick Ligation™ buffer inhibits transformation 
by electroporation reducing transformation efficiency and in some cases cause arcing in the 
electroporation cuvettes. We have also successfully used standard T4 ligase approaches with 
extended incubation times. 
18.  If using the pNOM-XP3 plasmid system, we recommend using E. coli strains compatible 
with T7 promoter systems such as BL21-Gold (DE3) or Tuner™ (DE3).  
19. We have used different T4 DNA ligase systems, including the Quick Ligation™ kit by 
NE Biolabs and the Fast-Link™ ligation kits by Epicentre. All have been successful.  
20. It is important to maximise the efficiency of ligation and the resulting transformation so as 
to maintain high molecular diversity. The SubSeq-plasmid DNA is a blunt end ligation so 
efficiency may be lower compared to ligation involving base overhangs.   
21. At this stage it is wise to isolate plasmid DNA using a “miniprep” approach to prevent 
total loss of the library DNA should large scale “maxi or midiprep” purification fail. Any 
unused culture can be divided into aliquots, frozen and stored until required.  
22. To facilitate downstream selection for DNA cassette insertion within the target gene, a 
KanR (Kanamycin) gene can be inserted within the DNA cassette between convenient 
restriction sites. We have used this approach successfully (14) although it does add extra steps 
to the process.  
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23. An additional step using the DNA cassette insert with KanR placed within the coding 
sequence (Subheading 3.4.1) has also been used to select solely for clones containing the 
DNA cassette insert. The additional step involves transforming E. coli with the ligation 
products of Subheading 3.4.4. The transformed cells were used to inoculate 50 ml LB broth 
supplemented with 25 µg/ml kanamycin and incubated at 37°C in a shaking incubator for ~16 
h. Plasmid DNA was isolated from the cultures and the KanR cassette removed by digestion 
with the appropriate restriction endonuclease. Restriction digests were separated by agarose 
gel electrophoresis and DNA bands corresponding to linear library plasmid DNA isolated and 
purified by gel extraction. Purified linear plasmid library DNA was recircularised by 
intramolecular ligation (Subheading 3.2.3) producing the domain/segment insert libraries, 
which was then used to transform E. coli TunerTM (DE3) cells by electroporation. The 
transformed cells were grown on LB agar supplemented with 100 μg/ml ampicillin and 150 
μM IPTG (if using the pNOM-XP3 plasmid), and incubated for 24 h at 37°C. 
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Fig. 1. Simple outline of the transposon-based random mutagenesis approach. The 
common first step involves the generation of a MuDel whole gene insertion library followed 
by its removal to generate random breaks in the target DNA. From this point, the methods 
diverge so that different mutational events can be sampled, namely trinucleotide deletion, 
trinucleotide exchange and domain insertion.  
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Fig. 2. Mechanism of MuDel-based mutagenesis. Step 1. MuDel Insertion. Two MlyI 
recognition sites (5’GAGTC(N)5ê) are placed 1 bp away from the site of transposon insertion. 
Insertion of MuDel results in the duplication of 5 bp (N1N2N3N4N5) of the target gene at the 
insertion point. Step 2. Digestion with MlyI removes MuDel together with 8 bp of the target 
DNA (4 bp at each end), which equates to removal of a contiguous 3 bp sequence from the 
starting target gene (N2N3N4). Step 3a. TND. Self-ligation at this stage results in the 
reconstitution of the full-length gene but with 3 bp (N2N3N4) removed. Step 3b. TriNEx. 
SubSeq is ligated into the gap vacated by MuDel. SubSeq contains two MlyI recognition sites 
strategically placed towards the ends of the cassette. One site is located so that MlyI will cut 
at the exact point where the target DNA joins SubSeq. The second site will cut 3 bp into 
SubSeq so donating 3 bp (NXNYNZ) to the target DNA. Step 4. Digestion with MlyI removes 
SubSeq but with 3 bp of its sequence now replacing the 3 bp deleted from the target gene. 
Step 5. Intramolecular ligation reforms the target gene but with one contiguous trinucleotide 
sequence replaced with another. 
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Fig. 3. Example permutations of the DNA insert cassette for protein domain/segment 
insertion. ORF refers to the different open reading frame libraries used to reconstitute an in-
frame chimeric gene on cassette insertion. Additional nucleotides required for frame 
correction are underlined. The first and last codons of the protein insertion coding region are 
shown on a black background. The rest of the intervening sequence is represented by 
DOMAIN. Three domain linking sequence variations are shown: (1) no linking sequences 
(None-X); (2) GlyGlySer linker (GGS-X); (3) Random short linker (Ran-X).  
 
 
 
